Takeda Pharmaceutical Co Ltd (HAM:TKD)
€ 25.5 -0.16 (-0.62%) Market Cap: 41.10 Bil Enterprise Value: 67.01 Bil PE Ratio: 22.79 PB Ratio: 0.95 GF Score: 75/100

Q3 2021 Takeda Pharmaceutical Co Ltd Earnings Call Transcript

Feb 04, 2021 / 11:00AM GMT
Release Date Price: €28.78 (-0.10%)
Operator

Good day, and welcome to the conference call of Takeda Pharmaceutical Company Limited. (Operator Instructions) Now we'll start the conference. Mr. O'Reilly, please go ahead.

Christopher David O;Reilly
Takeda Pharmaceutical Company Limited - Global Head of IR & Global Finance

' -

[Interpreted] Thank you very much for your participation in this conference call for the financial results for the third quarter of fiscal year 2020. My name is Christopher O'Reilly, Global Head of Investor Relations.

Before starting, I'd like to remind everyone that we will be discussing forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those discussed today. The factors that could cause our actual results to differ materially are discussed in our most recent Form 20-F and in our other SEC filings. Please also refer to the important notice on Page 1 of this presentation.

Now please let me introduce today's presenters and panel. Christophe Weber, President

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot